miRagen Therapeutics to Present at Biotech Showcase 2012

Published: Jan 06, 2012

BOULDER, Colo.--(BUSINESS WIRE)--MiRagen Therapeutics, Inc., a biopharmaceutical company focused on improving patients’ lives by developing innovative microRNA (miRNA)-based therapeutics for cardiovascular and muscle disease, announced today that William S. Marshall, Ph.D., President and Chief Executive Officer, will present at the Biotech Showcase 2012 in San Francisco. Dr. Marshall’s presentation will take place on Monday, January 9, 2012, at 10:45 a.m. PST at the Parc 55 Wyndham hotel and will provide an overview of the company, including key events, accomplishments and its focus in 2012.

Back to news